Inventaire - your friends and communities are your best library - Inventaire

Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer

author

Young Ju Jung

In-Jae Oh

Youndong Kim

Jong Ha Jung

Minkyoung Seok

Woochang Lee

Cheol Kyu Park

Jung-Hwan Lim

Young-Chul Kim

Woo-Sung Kim

Chang-Min Choi

published in: Journal of Korean Medical Science

date of publication: 2018-12-13

language: English

main subject: biomarker

Cites articles 19

Date

Title

Authors

2017-07-05

Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules

Charles E Birse, Harvey I Pass
2016

Cancer statistics, 2016
2016-10-05

Development of a Protein Biomarker Panel to Detect Non-Small-Cell Lung Cancer in Korea.
2015-01-01

Nucleic acid-based aptamers: applications, development and clinical trials

Kislay Roy, Raj Bawa, Jagat R Kanwar
2015-07-01

Trends in aptamer selection methods and applications

Hikmet Budak
2014-03-01

Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement

Michael P. Pignone, United States Preventive Services Task Force, Virginia A. Moyer
2014-04-22

Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.
2014-08-01

Validation of a blood protein signature for non-small cell lung cancer

Harvey I Pass
2013-05-01

Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

David P Naidich
2013-05-01

Results of initial low-dose computed tomographic screening for lung cancer

Timothy R. Church, Denise R. Aberle, Christine Berg
2013-08-26

The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology

Timothy R. Church, Paul F Pinsky
2013-10-01

A blood-based proteomic classifier for the molecular characterization of pulmonary nodules

Nathan D Price, Harvey I Pass
2012-04-11

EarlyCDT®-Lung test: improved clinical utility through additional autoantibody assays

Peter Boyle, Jared Allen
2011-08-04

Reduced lung-cancer mortality with low-dose computed tomographic screening

Jonathan Clapp, Denise R. Aberle, Meridith Blevins, Christine Berg
2010-12-07

Aptamer-based multiplexed proteomic technology for biomarker discovery

Dylan Flather
2010-12-07

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer

Harvey I Pass
2006-05-01

Prevalence of benign disease in patients undergoing resection for suspected lung cancer
2005-06-01

Lung cancer screening with low-dose helical CT in Korea: experiences at the Samsung Medical Center

SeMin Chong, O Jung Kwon, Kyung Soo Lee
2000-03-01

Aptamers as therapeutic and diagnostic agents

Article - wd:Q60956984

Welcome to Inventaire

the library of your friends and communities

you are offline